ONCO/REVEAL
LIVE

Serial Number

87982295

Owner

Pillar Biosciences, Inc.

Attorney

Marcus Assefa

First Use Date

May 20, 2019

Filing Date

Sep 22, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ONCO/REVEAL Trademark

Serial Number: 87982295 • Registration: 6114090

ONCO/REVEAL is a trademark filed by Pillar Biosciences, Inc. on September 22, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Pillar Biosciences, Inc. (17 trademarks)

Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

September 22, 2017

Registration Date

July 28, 2020

First Use Anywhere

May 20, 2019

First Use in Commerce

May 20, 2019

Published for Opposition

March 20, 2018

Goods & Services

Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 28, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 26, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 25, 2020 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2020 CRFA
ASSIGNED TO LIE
May 29, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 26, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 26, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 26, 2019 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2019 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Nov 13, 2019 SUPC
DIVISIONAL PROCESSING COMPLETE
Nov 13, 2019 DPCC
SOU EXTENSION 3 GRANTED
Nov 13, 2019 EX3G
USE AMENDMENT FILED
Nov 11, 2019 IUAF
DIVISIONAL REQUEST RECEIVED
Nov 11, 2019 DRRR
SOU EXTENSION 3 FILED
Nov 11, 2019 EXT3
TEAS REQUEST TO DIVIDE RECEIVED
Nov 11, 2019 ERTD
SOU TEAS EXTENSION RECEIVED
Nov 11, 2019 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 11, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2019 EXRA
CORRECTED NOA E-MAILED
May 30, 2019 NOAC
DIVISIONAL PROCESSING COMPLETE
May 29, 2019 DPCC
SOU EXTENSION 2 GRANTED
May 29, 2019 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 29, 2019 AITU
DIVISIONAL REQUEST RECEIVED
May 10, 2019 DRRR
SOU EXTENSION 2 FILED
May 10, 2019 EXT2
TEAS REQUEST TO DIVIDE RECEIVED
May 10, 2019 ERTD
SOU TEAS EXTENSION RECEIVED
May 10, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2018 EXRA
SOU EXTENSION 1 GRANTED
Nov 15, 2018 EX1G
SOU EXTENSION 1 FILED
Nov 15, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 15, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 15, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2017 NWOS
NEW APPLICATION ENTERED
Sep 26, 2017 NWAP